Literature DB >> 385025

A single dose comparison of piretanide and bumetanide in congestive cardiac failure.

M Homeida, C J Roberts, S L Dombey.   

Abstract

1 This study has compared the diuresis produced by a single oral administration of 6 mg piretanide, 9 mg piretanide and 1 mg bumetanide in a group of nine patients with cardiac failure using a balanced randomized design. 2 The natriuresis and kaliuresis produced in the first 6 h after administration of piretanide 9 mg and bumetanide 1 mg were similar. Piretanide 6 mg produced a lesser response. 3 There was evidence of sodium and water conservation following the diuresis for up to 48 h with all three treatments. 4 The patterns of urate and calcium excretion were similar for the two diuretics.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 385025      PMCID: PMC1429765          DOI: 10.1111/j.1365-2125.1979.tb05817.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  9 in total

1.  Relationship between urate retention and electrolyte excretion during treatment with loop diuretics [proceedings].

Authors:  W Bogie; M Homeida; C J Roberts; F Roberts
Journal:  Br J Clin Pharmacol       Date:  1977-06       Impact factor: 4.335

2.  Renal action, therapeutic use, and pharmacokinetics of the diuretic bumetanide.

Authors:  D L Davies; A F Lant; N R Millard; A J Smith; J W Ward; G M Wilson
Journal:  Clin Pharmacol Ther       Date:  1974-02       Impact factor: 6.875

3.  Factors affecting urate excretion following diuretic administration in man.

Authors:  T H Steele; S Oppenheimer
Journal:  Am J Med       Date:  1969-10       Impact factor: 4.965

4.  The natural history of congestive heart failure: the Framingham study.

Authors:  P A McKee; W P Castelli; P M McNamara; W B Kannel
Journal:  N Engl J Med       Date:  1971-12-23       Impact factor: 91.245

5.  The influence of hypertonic saline infusions upon the fractional reabsorption of urate and other ions in normal and hypertensive man.

Authors:  P J Cannon; D S Svahn; F E Demartini
Journal:  Circulation       Date:  1970-01       Impact factor: 29.690

6.  Kinetic and dynamic comparison of piretanide and furosemide.

Authors:  J R Lawrence; A F Ansari; H L Elliott; D J Sumner; G F Brunton; B Whiting; R Whitesmith
Journal:  Clin Pharmacol Ther       Date:  1978-05       Impact factor: 6.875

7.  On the clinical evaluation of diuretics with particular reference to a new phthalimidine diuretic, clorexolone.

Authors:  A F Lant; W I Baba; G M Wilson
Journal:  Clin Pharmacol Ther       Date:  1966 Mar-Apr       Impact factor: 6.875

8.  Effects of piretanide, bumetanide and frusemide on electrolyte and urate excretion in normal subjects.

Authors:  C J Roberts; M Homeida; F Roberts; W Bogie
Journal:  Br J Clin Pharmacol       Date:  1978-08       Impact factor: 4.335

9.  Effect of frusemide on calcium excretion.

Authors:  J A Tambyah; M K Lim
Journal:  Br Med J       Date:  1969-03-22
  9 in total
  7 in total

1.  Comparison of the short-term effects of the loop diuretic piretanide and furosemide in patients with renal insufficiency.

Authors:  C Marone; F C Reubi; W Lahn
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

2.  Acute haemodynamic effects of a single intravenous dose of piretanide in congestive heart failure.

Authors:  H Valette; J L Hébert; E Apoil
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

3.  Assessment of natriuretic drugs.

Authors:  C J Roberts; T K Daneshmend
Journal:  Br J Clin Pharmacol       Date:  1981-10       Impact factor: 4.335

4.  The effects of a combination of piretanide and triamterene in healthy subjects.

Authors:  T K Daneshmend; M Homeida; C J Roberts; S Dombey
Journal:  Br J Clin Pharmacol       Date:  1981-01       Impact factor: 4.335

Review 5.  Piretanide. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-06       Impact factor: 9.546

6.  Oral piretanide in chronic renal failure.

Authors:  I S Henderson; T J Beattie; A C Kennedy; S L Dombey
Journal:  Br J Clin Pharmacol       Date:  1982-12       Impact factor: 4.335

Review 7.  Bumetanide. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use.

Authors:  A Ward; R C Heel
Journal:  Drugs       Date:  1984-11       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.